Fang W, Li X, Wang Q, Meng X, et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial. BMJ 2025;389:e085680.
PMID: 40473437